American Vanguard To Acquire The U.S. Rights To Crop-Protection Brands Caparol, Evik, Prime+, And Agri-Flex From Syngenta; Terms Not Disclosed; Expects $7M+ Of Annual Net Sales From Four Brands

The transaction includes the applicable U.S. end-use product registrations and trademarks. Financial terms were not disclosed, but the transaction is expected to be accretive to earnings over the next year and have a positive impact on the American Vanguard's leverage ratio over the next twelve months and beyond.

The acquired products serve a range of important agricultural markets:

• Caparol® is a long-established residual herbicide used to control broadleaf weeds and grasses in cotton, vegetables and peas. The product also offers strong utility in burndown tank-mix programs.
• Evik® is a niche herbicide with strong brand recognition, used primarily in sugarcane and pineapple production.
• Prime+® is a specialized plant growth regulator used for sucker control in tobacco. It supports labor-saving, single-application programs in key tobacco-producing states.
• Agri-Flex® is an established insecticide used in specialty crops, particularly Florida citrus. It provides residual control of key pests and serves as a valuable rotational tool in integrated pest management programs.

"The addition of these well-established brands to the AMVAC portfolio expands and strengthens our offerings in core crops while providing American farmers solutions for their specific field challenges," said Dak. Kaye, Chief Executive Officer of American Vanguard. "Each of these products has a recognized position in its respective market and addresses important needs across cotton, vegetables, sugarcane, pineapple, tobacco and specialty-crop production. Their addition further diversifies our portfolio while enhancing our ability to support growers with dependable, crop-protection solutions throughout the growing season."

"Additionally, these acquisitions are projected to deliver over $7 million of annual net sales and strengthen our plan to have $100 million in new product sales by 2030 and help solidify our 2028 midterm plan of sales of $600 million by the end of 2028 on annualized basis," Kaye continued. "As we complete the registration-transfer process with Syngenta, our priority will be to ensure a smooth transition, maintain product availability and provide uninterrupted service to customers and channel partners across the United States."